Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-24,732
Closed -$893K 1194
2022
Q1
$893K Sell
24,732
-1,918
-7% -$94.4K ﹤0.01% 900
2021
Q4
$2.04M Sell
26,650
-2,136
-7% -$188K 0.01% 766
2021
Q3
$2.77M Sell
28,786
-2,089
-7% -$228K 0.01% 665
2021
Q2
$3.29M Sell
30,875
-1,790
-5% -$176K 0.01% 451
2021
Q1
$2.93M Buy
+32,665
New +$3.6M 0.01% 618
2020
Q2
Sell
-11,927
Closed -$184K 752
2020
Q1
$184K Sell
11,927
-2,867
-19% -$60.3K ﹤0.01% 662
2019
Q4
$324K Buy
+14,794
New +$243K ﹤0.01% 751

Other funds holding CRNC

Natixis's CRNC Position: Q2 2022 in Review

Natixis sold out of Cerence (CRNC) in Q2 2022, closing a stake of 24,732 shares — an estimated $893K sold.

Natixis first reported a position in CRNC in Q4 2019 and held it in 7 quarters. The position peaked at $3.29M in Q2 2021. 270 funds tracked by Wall St. Rank hold CRNC as of Q2 2022.

  • Natixis reported no remaining Cerence position as of Q2 2022 after selling out during the quarter.
  • Natixis sold 24,732 Cerence shares in Q2 2022, an estimated $893K.
  • Natixis first reported a position in Cerence in Q4 2019 and held it in 7 quarters.
  • Natixis's Cerence position peaked at $3.29M in Q2 2021.
  • 270 funds tracked by Wall St. Rank held Cerence as of Q2 2022.

Based on Natixis's 13F filing for Q2 2022, filed 12 Aug 2022.